Hepatitis C virus (HCV) is a silent and deadly virus. It causes relentless liver damage, leading to debilitating illness and death. With 71 million cases globally and half a million deaths annually, HCV is a serious public health threat. However, there is new hope. A new class of medicines can cure HCV. This offers an unprecedented opportunity for its elimination in a whole population. Rwanda is disproportionally affected by HCV, jeopardizing its population health aspirations. A significant political commitment by Rwanda underpins the partnership between ICAP at Columbia University and the Ministry of Health (MOH) to eliminate HCV. This novel project will include nationwide community mobilization; training of health and community workers; establishing laboratory infrastructure; providing treatment to all persons with HCV; and tracking progress towards elimination. The goal is for Rwanda to be the first to eliminate HCV, proving that it can be done and inspiring others to follow.
Trustees of Columbia University in the City of New Yorkwebsite: https://icap.columbia.edu/
Charity, fund, non-governmental organization, religious institution, school, or other entity